There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
Ladies and gentlemen welcome to the presentation of BNP Paribas Consolidated Results 2011. Jean-Laurent Bonnafé, CEO of the group who will present the results along with COOs, Chief Operating Officers, Georges de Courcel, Phili Bordenave and François...
Like us and you'll find top breaking news in your Facebook newsfeed. Sign up for our daily email newsletter and get top stories and breaking news delivered to your inbox. MIDTOWNWe've commented before on the under-the-radar feel to Centurion, the...
BEVERLY HILLS, CA - MAY 12: 2011 Orange Ball Honoree Dr. Iris Loew-Friedrich of UCB, Amanda Cowan and Executive Council Chairman of Lupus LA Adam Selkowitz onstage at the 11th Annual Lupus LA Orange Ball held at the Beverly Wilshire Four Seasons Hotel on... View Photo »
UCB is committed to making a difference in the lives of people affected by Crohn's disease ... At UCB, we consider it a privilege to provide assistance to individuals using education to live more fully outside the limitations of Crohn's disease.
Rolf Halden's team performs detailed analyses of umbilical cord blood (UCB), identifying a total of 1,210 proteins using mass spectroscopy. The findings represent a 6-fold increase in the number UCB proteins thus far described -- a significant advance:...
13 February 2012 Pial Ganguli Please Login to read the full article. UCB has entered into a multi-year strategic collaboration with private, Nodality, aimed at using the latter's single cell network profiling technology to "assist the development of...
(UCBJF) along with Nodality Inc. agreed for a strategic collaboration under which they will utilize Nodality’s proprietary Single Cell Network Profiling (SCNP) technology to develop several of UCB’s compounds. The multi-year agreement will initially be...
BEVERLY HILLS, CA - MAY 12: 2011 Orange Ball Honoree Dr. Iris Loew-Friedrich of UCB speaks onstage at the 11th Annual Lupus LA Orange Ball held at the Beverly Wilshire Four Seasons Hotel on May 12, 2011 in Beverly Hills, California. View Photo »
UCB is committed to making a difference in the lives of people affected by Crohn's disease ... At UCB, we consider it a privilege to provide assistance to individuals using education to live more fully outside the limitations of Crohn's disease.
Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential GBI Research, the leading business intelligence provider, has released its latest report, “Nanotechnology in Drug Delivery - Technological...
"This is a dramatic change to the pipeline for Vernalis." There are 35m prescriptions for cough and cold remedies in the US every year and there is only one slow-release product on the market, UCB's Tussionex. Vernalis' fundraising at 20p a share,...
UCB (Euronext: UCB), is a global biopharmaceutical manufacturer headquartered in Brussels. It focuses on novel therapeutic solutions for patients with severe diseases treated by specialists, particularly in the fields of central nervous system disorders (including epilepsy), inflammatory disorders (including allergy) and oncology. Full Article
There are no results for this module. Edit the module to change the search term used to query related quotes.
We found no quotes related to UCB.
